Advanced tests for skin and respiratory sensitization assessment

Altex

Volumn 30, Issue 2, 2013, Pages 231-252

  Rovida, Costanza ^a   Martin, Stefan F ^b   Vivier, Manon ^c   Weltzien, Hans Ulrich ^d   Roggen, Erwin ^e  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^e NOVOZYMES A S   (Denmark)

Author keywords

3d cultures; In vitro methods; INTEGRATED Testing Strategy; Respiratory sensitization; Skin sensitization

Indexed keywords

ALLERGEN; ANTIGEN; CXCL1 CHEMOKINE; CYCLIC AMP; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HAPTEN; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MULTIDRUG RESISTANCE PROTEIN; RANTES; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC REACTION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ANTIGENICITY; ATOPIC DERMATITIS; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL VIABILITY; CHEMICAL MODIFICATION; CONFERENCE PAPER; CONTACT ALLERGY; CONTACT DERMATITIS; COVALENT BOND; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DOSE RESPONSE; ELECTROPHILICITY; FOLLOW UP; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INNATE IMMUNITY; INTRACELLULAR SIGNALING; KERATINOCYTE; LANGERHANS CELL; METABOLIC ACTIVATION; METABOLIC CAPACITY; MOLECULAR WEIGHT; NATURAL KILLER T CELL; NONHUMAN; NUCLEOPHILICITY; OCCUPATIONAL ASTHMA; PROCEDURES; PROTEIN BINDING; PROTEIN INTERACTION; PROTEOMICS; QUALITY CONTROL; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; RESPIRATORY SENSITIZATION; RESPIRATORY TRACT ALLERGY; RISK ASSESSMENT; SENSITIZATION; SIGNAL TRANSDUCTION; SKIN ALLERGY; SKIN SENSITIZATION; SKIN TEST; STRATUM CORNEUM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; VALIDATION PROCESS; XENOBIOTIC METABOLISM;

EID: 84877623483     PISSN: 1868596X     EISSN: 18688551     Source Type: Journal    
DOI: 10.14573/altex.2013.2.231     Document Type: Conference Paper

References (83)

1. Aeby, P., Ashikaga, T., Bessou-Touya, S., et al. (2010). Identifying and characterizing chemical skin sensitizers without animal testing: Colipa's research and method development program. Toxicol In Vitro 24, 1465-1473.
2. Akiba, H., Kehren, J., Ducluzeau, M. T., et al. (2002). Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ TC1 cells inducing keratinocyte apoptosis. J Immunol 168, 3079-3087.
3. Antonopoulos, C., Cumberbatch, M., Mee, J. B., et al. (2008). IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis. J Leukoc Biol 83, 361-367.
4. Ashikaga, T., Yoshida, Y., Hirota, M., et al. (2006). Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLATprotocol. Toxicol In Vitro 20, 767-773.
5. Ashikaga, T., Sakaguchi, H., Okamoto, K., et al. (2008). Assessment of the human cell line activation test (h-CLAT) for skin sensitization; Result of the first Japanase inter-laboratory study. AATEX 13, 27-35.
6. Ashikaga, T., Sakaguchi, H., Sono, S., et al. (2010). A comparative evaluation of in vitro skin sensitisation tests: the human Cell-line Activation Test (h-CLAT) versus the Local Lymph Node Assay (LLNA). ATLA 38, 275-284.
7. Baron, J. M., Holler, D., Schiffer, R., et al. (2001). Expression of multiple cytochrome p450 enzymes and multidrug resistance-Associated transport proteins in human skin keratinocytes. J Invest Dermatol 116, 541-548.
8. Bergstrom, M. A., Ott, H., Carlsson, A., et al. (2007). A skin-like Cytochrome P450 cocktail activates pro-haptens to contact allergenic metabolites. J Invest Dermatol 127, 1145-1153.
9. Blackshear, P. J. (2002). Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem Soc Trans 30, 945-952.
10. Carbone, T., Nasorri, F., Pennino, D., et al. (2010). Clinical immunology CD56highCD16-CD62L-NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses. J Immunol 184, 1102-1110.
11. Casati, S., Aeby, P., Kimber, I., et al. (2009). Selection of chemicals for the development and evaluation of in vitro methods for skin sensitisation test. ATLA 37, 305-312.
12. Corsini, E., Mitjans, M., Galbiati, V., et al. (2009). Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. Toxicol In Vitro 23, 789-796.
13. Cumberbatch, M., Dearman, R. J., Antopoulos, C., et al. (2001). Interleukin-18 induces Langerhans cell migration by a tumor necrosis factor-α and IL-1β-dependent mechanism. Immunology 102, 323-330.
14. Daneshian, M., Leist, M., and Hartung, T. (2010). The Center for Alternatives to Animal Testing - Europe (CAAT-EU): a transatlantic bridge for the paradigm shift in toxicology. ALTEX 27, 63-69.
15. Dietz, L., Bosque, A., Pankert, P., et al. (2009). Quantitative DY-maleimide-based proteomic 2-DElabelling strategies using human skin proteins. Proteomics 9, 4298-4308.
16. Dietz, L., Esser, P. R., Schmucker, S. S., et al. (2010). Tracking human contact allergens: From mass spectrometric identification of peptide-bound reactive small chemicals to chemical-specific naive human t-cell priming. Toxicol Sci 117, 336-347.
17. Dietz, L., Kinzebach, S., Ohnesorge, S., et al. (2012). Proteomic allergen-peptide/protein interaction assay for the identification of human skin sensitizers. Toxicol In Vitro, Epub ahead of print. http://dx.doi.org/10.1016/j. tiv.2012.08.013
18. Dos Santos, G. G., Spiekstra, S. W., Sampat-Sardjoepersad, S. C., et al. (2011). A potential in vitro epidermal equivalent assay to determine sensitizer potency. Toxicol In Vitro 25, 347-357.
19. Esser, P. R., Wölfle, U., Dürr, C., et al. (2012). Contact sensitizers induce skin inflammation via ROS and hyaluronic acid degradation in humans and mice. PLoS One 7, e41340.
20. Fleischel, O., Giménez-Arnau, E., and Lepoittevin, J. P. (2009). Nuclear magnetic resonance studies on the covalent modification of amino acids thiol and amino residues by monofunc- tional aryl 13C-isocyanates, models of skin and respiratory sensitizers. Transformation of thiocarbamates into urea adducts. Chem Res Toxicol 22, 1106-1115.
21. Galbiati, V., Mitjans, M., Lucchi, L., et al. (2011). Further development of the NCTC 2544 IL-18 assay to identify in vitro contact allergens. Toxicol In Vitro 25, 724-732.
22. Galbiati, V., Carne, A., Mitjans, M., et al. (2012). Isoeugenol destabilizes IL-8 mRNA expression in THP-1 cells through induction of the negative regulator of mRNA stability tristetraprolin. Arch Toxicol 86, 239-248.
23. Geiger, R., Duhen, D., Lanzavecchia, A., and Sallusto, F. (2009). Human naive and memory CD4+ T-cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T-cells. J Exp Med 206, 1525-1534.
24. Gerberick, G. F., Vassallo, J., Bailey, R., et al. (2004). Development of peptide reactivity assay for screening contact allergens. Toxicol Sci 81, 332-343.
25. Gerberick, F., Vassallo, J., Foertsch, L., et al. (2007a). Quantification of chemical peptide reactivity for screening contact allergens. Toxicol Sci 97, 417-427.
26. Gerberick, F., Vassallo, J., Foertsch, L., et al. (2007b). Quantification of Chemical peptide reactivity for screening contact allergens: A classification tree model approach. Toxicol Sci 97, 417-427.
27. Gerberick, F., Troutman, J., Foertsch, L., et al. (2009). Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system. Toxicol Sci 112, 164-174.
28. Goebel, C., Aeby, P., Ade, N., et al. (2012). Guiding principles for the implementation of non-Animal safety assessment approaches for cosmetics: skin sensitisation. Regul Toxicol Pharmacol 63, 40-52.
29. Hagvall, L., Baron, J. M., Börje, A., et al. (2008). Cytochrome P450-mediated activation of the fragrance compound geraniol forms potent contact allergens. Toxicol Appl Pharmacol 233, 308-313.
30. Hartung, T., Bremer, S., Casati, S., et al. (2004). A modular approach to the ECVAM principles on test validity. ATLA 32, 467-472.
31. Heiss, K., Junkes, C., Guerreiro, N., et al. (2005). Subproteomic analysis of metal-interacting proteins in human B cells. Proteomics 5, 3614-3622.
32. Hennino, A., Vocanson, M., Toussaint, Y., et al. (2007). CD8+ Tcells initiate atopic dermatitis lesions. J Immunol 178, 5571-5577.
33. Hermanns, M. I., Fuchs, S., Wenzelm, K., et al. (2009). A primary human coculture model of the alveolo-capillary unit to study mechanisms of injury to the peripheral lung. Cell Tissue Res 336, 91-105.
34. Hooyberghs, J., Schoeters, E., Lambrechts, N., et al. (2008). A cell-based in vitro alternative to identify skin sensitizers by gene expression. Toxicol Appl Pharmacol 231, 103-111.
35. Jaworska, J., Harol, A., Kern, P. S., and Gerberick, G. F. (2011). Integrating non-Animal test information into an adaptive testing strategy - skin sensitization proof of concept case. ALTEX 28, 211-225.
36. Johansson, H., Lindstedt, M., Albrekt, A. S., and Borrebaeck, C. (2011). A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests. BMC Genomics 12, 399.
37. Kaplan, D. H., Igyártó, B. Z., and Gaspari, A. A. (2012). Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol 12, 114-124.
38. Kehren, J., Desvignes, C., Krasteva, M., et al. (1999). Cytotoxicity is mandatory for CD8+ Tcell-mediated contact hypersensitivity. J Exp Med 189, 779-786.
39. Kimber, I., Agius, R., Basketter, D. A., et al. (2007). Chemical respiratory allergy: opportunities for hazard identification and characterisation. ATLA 35, 243-265.
40. Krasteva, M., Kehren, J., Sayag, M., et al. (1999). Contact dermatitis II. Clinical aspects and diagnosis. Eur J Dermatol 9, 144-159.
41. Lambrechts, N., Vanheel, H., Nelissen, I., et al. (2010a). Assessment of chemical skin sensitizing potency by an in vitro assay based on human dendritic cells. Toxicol Sci 116, 122-129.
42. Lambrechts, N., Vanheel, H., Hooyberghs, J., et al. (2010b). Gene markers in dendritic cells unravel pieces of the skin sensitization puzzle. Toxicology Letters 196, 95-103.
43. Lambrechts, N., Nelissen, I., Van Tendeloo, V., et al. (2011). Functionality and specificity of gene markers for skin sensitization in dendritic cells. Toxicology Letters 203, 106-110.
44. Landsteiner, K. And Jacobs, J. (1936). Studies on the sensitization of animals with simple chemical compounds. J Exp Med 64, 625-639.
45. Martin, S. F., Esser, P. R., Schmucker, S., et al. (2010). T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays. Cell Mol Life Science 67, 4171-4184.
46. Martin, S. F., Esser, P. R., Weber, F. C., et al. (2011). Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy 66, 1152-1163.
47. Martin, S. F. (2012). Contact dermatitis: from pathomechanisms to immunotoxicology. Exp Dermatol 21, 382-389.
48. Maxwell, G., Aeby, P., Ashikaga, T., et al. (2011). Skin sensitisation: The Colipa strategy for developing and evaluating non-Animal test methods for risk assessment. ALTEX 28, 50-55.
49. Megherbi, R., Kiorpelidou, E., Foster, B., et al. (2009). Role of protein haptenation in triggering maturation events in the dendritic cell surrogate cell line THP-1. Toxicol Appl Pharmacol 238, 120-132.
50. Mitjans M., Viviani B., Lucchi L., et al. (2008). Role of p38 MAPK in the selective release of IL-8 induced by chemical allergen in naive THp-1 cells. Toxicol In Vitro 22, 386-395.
51. Mitjans, M., Galbiati, V., Lucchi, L., et al. (2010). Use of IL-8 release and p38 MAPK activation in THP-1 cells to identify allergens and to assess their potency in vitro. Toxicol In Vitro 24, 1803-1809.
52. NRC (2007). Toxicity Testing in the Twenty-first Century: A Vision and A Strategy. Washington DC, USA: National Academies Press. http://www.nap.edu/ catalog.php?record-id=11970
53. Nukada, Y., Ashikaga, T., Miyazawa, M., et al. (2012). Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency. Toxicol In Vitro 26, 1150-1160.
54. OECD (2005). Test Guideline 34. Guidance document on the validation and international acceptance of new or updated test methods for hazard assessment. http://www.oecd.org/officialdocuments/displaydocumentpdf?cote=env/jm/mono(2005) 14&doclanguage=en (accessed on 17th June 2012).
55. Okamura, H., Tsutsui, H., Komatsu, T., et al. (1995). Cloning of a new cytokine that induces IFN-γ production by T-cells. Nature 378, 88-91.
56. Ott, H., Wiederholt, T., Bergström, A. M., et al. (2010). High-resolution transcriptional profiling of chemical-stimulated dendritic cells identifies immunogenic contact allergens, but not pro-haptens. Skin Pharmacol Physiol 23, 213-224.
57. Ouwehand, K., Santegoets, S. J., Bruynzeel, D. P., et al. (2008). CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis. European J Immunol 38, 3050-3059.
58. Ouwehand, K., Scheper, R. J., de Gruijl, T. D., and Gibbs, S. (2010). Epidermis-to-dermis migration of immature Langerhans cells upon topical irritant exposure is dependent on CCL2 and CCL5. European J Immunol 40, 2026-2034.
59. Ouwehand, K., Spiekstra, S. W., Waaijman, T., et al. (2011). Technical advance: Langerhans cells derived from a human cell line in a full-thickness skin-equivalent undergo allergen-induced maturation and migration. J Leukoc Biol 90, 1027-1033.
60. Pennino, P., Eyerich, K., Scarponi, C., et al. (2010). Cellular immunology and immune regulation IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes. J Immunol 184, 4880-4888.
61. Raghavan, B., Martin, S. F., Esser, P. R., et al. (2012). Metal allergens nickel and cobalt facilitate human Toll-like receptor 4 homodimerisation independently of MD2. EMBO Reports 13, 1109-1115.
62. Rees, B., Spiekstra, S. W., Carfi, M., et al. (2011). Inter-laboratory study of the in vitro DC migration assay for identification of contact allergens. Toxicol In Vitro 25, 2124-2134.
63. Reuter, H., Spieker, J., Gerlach, S., et al. (2011). In vitro detection of contact allergens: Development of an optimized protocol using human peripheral blood monocyte-derived dendritic cells. Toxicol In Vitro 25, 315-323.
64. Richter, A., Schmucker, S., Esser, P. R., et al. (2012). Human T-cell priming assay (hTCPA) for the identification of contact allergens based on naive T-cells and DC - IFN-γ and TNF-α readout. Toxicol In Vitro, Epub ahead of print. doi: 10.1016/j.tiv.2012.08.007
65. Rovida, C., Basketter, D., Casati, S., et al. (2007). Management of an integrated project (Sens-it-iv) to develop in vitro tests to assess sensitisation. ATLA 35, 317-322.
66. Sakaguchi, H., Ashikaga, T., Miyazawa, M., et al. (2006). Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. Toxicol In Vitro 20, 774-784.
67. Sakaguchi, H., Ryan, C., Ovigne, J. M., et al. (2010). Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials. Toxicol In Vitro 24, 1810-1820.
68. Schmidt, M., Raghavan, B., Müller, V., et al. (2010a). A crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nature Immunol 11, 814-819.
69. Schmidt, M., Hupe, M., Endres, N., et al. (2010b). The contact allergen nickel sensitizes primary human endothelial cells and keratinocytes to TRAIL-mediated apoptosis. J Cell Mol Med 14, 1760-1776.
70. Schmidt, M. And Goebeler, M. (2011). Nickel allergies: Paying the Toll for innate immunity. J Mol Med (Berl) 89, 961-970.
71. Schoeters, E., Verheyen, G. R., Nelissen, I., et al. (2007). Microarray analyses in dendritic cells reveal potential biomarkers for chemical-induced skin sensitization. Mol Immunol 44, 3222-3233.
72. Skazik, C., Heise, R., Ott, H., et al. (2011). Active transport of contact allergens in human monocyte-derived dendritic cells is mediated by multidrug resistance related proteins. Arch Biochem Biophys 508, 212-216.
73. Spiekstra, S. W., Dos Santos, G. G., Scheper, R. J., and Gibbs, S. (2009). Potential method to determine irritant potency in vitro - Comparison of two reconstructed epidermal culture models with different barrier competency. Toxicol In Vitro 23, 349-355.
74. Switalla, S., Lauenstein, L., Prenzler, F., et al. (2010). Natural innate cytokine response to immunomodulators and adjuvants in human precision-cut lung slices. Toxicol Appl Pharmacol 246, 107-115.
75. Teunis, M., Corsini, E., Smits, M., et al. (2012). Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 to determine the skin sensitizing capacity and epidermal equivalent assay to determine sensitizer potency. Toxicol In Vitro, Epub ahead of print.
76. Thierse, H. J., Moulon, C., Allespach, Y., et al. (2004). Metal-protein complex-mediated transport and delivery of Ni2+ to TCR/MHC contact sites in nickel-specific human T cell activation. J Immunol 172, 1926-2119.
77. Thierse, H. J., Helm, S., Pink, M., and Weltzien, H. U. (2007). Novel fluorescence assay for tracking molecular and cellular allergen-protein interactions. J Immunol Methods 328, 14-20.
78. Troutman, J. A., Foertsch, L. M., Kern, P. S., et al. (2011). The incorporation of lysine into the peroxidase peptide reactivity assay for skin sensitization assessments. Toxicol Sci 122, 422-436.
79. Viemann, D., Schmidt, M., Tenbrock, K., et al. (2007). The contact allergen nickel triggers a unique inflammatory and proangiogenic gene expression pattern via independent activation of NF-κB and HIF-1α. J Immunol 178, 3198-3207.
80. Vocanson, M., Saint-Mezard, P., Cluzel-Tailhardat, M., et al. (2006). CD8+ Tcells are effector cells of contact dermatitis to common skin allergens in mice. J Invest Dermatol 126, 815-820.
81. Vocanson, M., Cluzel-Tailhardat, M., Poyet, G., et al. (2008). Depletion of human peripheral blood lymphocytes in CD25+ cells allows for the sensitive in vitro screening of contact allergens. J Invest Dermatol 128, 2119-2122.
82. Vocanson, M., Hennino, A., Rozières, A., et al. (2009). Effectors and regulatory mechanisms in allergic contact dermatitis. Allergy 64, 1699-1714.
83. Vocanson, M., Hennino, A., Rozieres, A., et al. (2010). Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of Th17/Th1 and regulatory Tcells. J Allergy Clin Immunol 126, 280-289.